Hola,
Are you new here?

COMPAR-EU

financed

Comparing effectiveness of self management interventions in 4 high priority chro...

Comparing effectiveness of self management interventions in 4 high priority chronic diseases in Europe COMPAR-EU aims to identify, compare, and rank the most effective and cost-effective self-management interventions (SMIs) for adults in Europe within four high-priority chronic conditions: type 2 diabetes, obesity, chronic obstruct... see more

31/12/2022

FUNDACION AVEDIS D...

6M€

Project Budget: 6M€

Project leader

FUNDACION AVEDIS DONABEDIAN PARA LA MEJORA DE... Otras actividades de apoyo a las empresas n.c.o.p. asociacion

TRL 4-5 | 50K€

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 8 Participantes

Financing granted El organismo H2020 notifico la concesión del proyecto The day 2022-12-31

SC1-PM-10-2017: Comparing the effectiveness of exis... Specific Challenge:Effective health care and prevention may be improved by additional evidence as to...

I+D

Cerrada does 8 years

0% 100% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

8 Participantes

FUNDACION AVEDIS DONABEDIAN...

1.35M€ | Leader

EUR

78.07K€ | participant

733.80K€ | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 61 months Date Start: 2017-11-23
End date: 2022-12-31

Project leader

FUNDACION AVEDIS DONABEDIAN PARA LA MEJORA DE... Otras actividades de apoyo a las empresas n.c.o.p. asociacion

TRL 4-5 | 50K€

Project Budget 6M€

participation deadline Sin fecha límite de participación.

Project description COMPAR-EU aims to identify, compare, and rank the most effective and cost-effective self-management interventions (SMIs) for adults in Europe within four high-priority chronic conditions: type 2 diabetes, obesity, chronic obstructive pulmonary disease, and heart failure. This project addresses an important gap in current knowledge applying network meta-analysis, an extension of meta-analysis methodology that allows multiple (rather than pairwise) comparisons of intervention effectiveness, to randomised controlled trials (RCTs) that meet the study inclusion criteria. This centralised analysis of an estimated 4000 RCTs will substantially help to overcome current problems associated with the dispersion and duplication of evidence. The work will be based on a validated taxonomy of SMIs and will prioritise outcomes from the patients’ perspective. In addition, a cost-effectiveness of the most effective SMIs will be estimated to provide insights into the economic consequences of adopting SMIs for societies, healthcare budgets, and patients. Contextual factors associated with successful interventions will also be studied. Drawing on our results, we will develop and pilot decision-making tools to facilitate access to evidence-based information on the most effective SMIs to key users through a user-friendly interactive platform. A multiprong strategy for exploitation of the research findings will lead to clear business cases for implementing it in different contexts within the heterogeneous EU health system. The end goal of the project is to have an impact in supporting policy-makers, guideline developers, researchers, industry, professionals and patients to make informed decisions on the identification and implementation of the most suitable SMIs, therefore contributing to the diffusion of the knowledge, healthcare sustainability and equity and promoting EU competitiveness in a globally emerging market.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers